Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.25
Bid: 37.50
Ask: 39.00
Change: 0.55 (1.44%)
Spread: 1.50 (4.00%)
Open: 38.25
High: 38.80
Low: 38.80
Prev. Close: 38.25
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2018 LTIP and Grant of Options to PDMRs

26 Mar 2018 07:00

RNS Number : 8401I
Venture Life Group PLC
26 March 2018
 

 

Venture Life Group plc

("Venture Life" or the "Company")

 

2018 Long Term Incentive Plan and Grant of Options to PDMRs

 

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it has granted further nominal-cost share options ("Options") over ordinary shares of 0.3p each in Venture Life ("Shares") under the Venture Life Group plc 2016 Long Term Incentive Plan ("LTIP").

 

On 23 March 2018 (the "Date of Grant"), Venture Life granted Options over a total of 1,358,806 Shares to its four Executive Directors. Vesting of the Options is subject to continued employment and the Company meeting objective performance conditions, namely the Company's Earnings Per Share ("EPS") performance and relative Total Shareholder Return (share price performance plus dividends added back, "TSR"). Half of the Options granted are subject to EPS performance and half subject to TSR performance.

 

This tranche of 1,358,806 Options will vest on 23 March 2021, subject to meeting the performance conditions set for the Company's EPS over the three financial years ending 31 December 2020 and TSR for the three years commencing 23 March 2018. The Options are exercisable at a price of 0.3p per Share.

 

Director

Position

No. of LTIPS in this issue

No. of LTIPS lapsed

Total number of shares held under option

Jerry Randall

Chief Executive Officer

 448,548

(203,390)

 2,436,252

Gianluca Braguti

Manufacturing Director

 360,650

(153,971)

 863,124

Sharon Collins

Commercial Director

 299,032

(135,593)

 2,074,575

Adrian Crockett

Chief Financial Officer

 250,576

0

 416,101

 

 

 1,358,806

(492,954)

 5,790,052

 

 

 

 

 

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

The lapsed options relate to options issued in 2015 that have now lapsed as the performance conditions attached to them were not met.

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Jerry Randall - Chief Executive Officer

Gianluca Braguti - Manufacturing Director

Sharon Collins - Commercial Director

Adrian Crockett - Chief Financial Officer

 

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for positions - all classified as PDMRs of Venture Life

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Venture Life Group plc

b)

 

LEI

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 0.3p each in Venture Life Group plc

b)

Identification code 

 

GB00BFPM8908

c)

 

Nature of the transaction 

 

Grant of Options over Ordinary Shares pursuant to the Venture Life Group plc 2017 Long Term Incentive Plan

 

d)

 

Price and volumes

Price - nil

Volumes:

Jerry Randall - 448,548 Ordinary Shares

Gianluca Braguti - 360,650 Ordinary Shares

Sharon Collins - 299,032 Ordinary Shares

Adrian Crockett - 250,576 Ordinary Shares

d)

 

Aggregated information 

- Aggregated volume

- Price

 N/a

 

e)

 

Date of the transaction 

23 March 2017

f)

Place of the transaction

Outside a trading venue

 

Name of authorised official of issuer responsible for making notification.

Peter Shepherd

 

Company Secretary to Venture Life Group plc

 

For further information please contact:

 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

 

Adrian Crockett, Chief Financial Officer

 

 

Northland Capital Partners Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3861 6625

Matthew Johnson/Edward Hutton (Corporate Finance)

 

Bob Pountney (Corporate Broking)

 

 

 

Turner Pope Investments (TPI) Ltd (Joint Broker)

+44 (0) 20 3621 4120

Andy Thacker

 

 

 

Walbrook PR

venturelife@walbrookpr.com or +44 (0) 20 7933 8780

Paul McManus/Anna Dunphy

+44 (0) 7980 541 893 / +44 (0) 7876 741 001

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGZFNKZGRZM
Date   Source Headline
9th Apr 20247:00 amRNSFinal Results for year ended 31 December 2023
4th Apr 20247:00 amRNSNotice of Results and Investor Presentation
19th Feb 20245:18 pmRNSHolding(s) in Company
6th Feb 202410:48 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTrading Update
20th Dec 20232:00 pmRNSHolding(s) in Company
28th Nov 202312:28 pmRNSHolding(s) in Company
22nd Nov 20234:05 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
31st Oct 20233:11 pmRNSHolding(s) in Company
17th Oct 20231:54 pmRNSHolding(s) in Company
25th Sep 20237:01 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Statement
5th Jul 20237:00 amRNSPDMR Shareholdings – Grant of Awards
26th Jun 20234:48 pmRNSDirector/PDMR Shareholding
25th May 20231:54 pmRNSDirector Dealings
22nd May 20233:01 pmRNSResults of AGM
22nd May 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSBoard Change
9th May 20237:00 amRNSNotice of Capital Markets Event
28th Apr 202310:05 amRNSAnnual Report and Notice of AGM
5th Apr 20231:53 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSFinal Results for year ended 31 December 2022
31st Mar 20237:00 amRNSInvestor Presentation
13th Mar 20237:00 amRNSUpdate re Revolving Credit Facility
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSTrading Statement
9th Jan 20237:00 amRNSLicensing and distribution agreements
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:37 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSAcquisition and trading update
10th Oct 20227:00 amRNSDirectorate Changes
23rd Sep 202211:08 amRNSInvestor Presentation
22nd Sep 20227:00 amRNSHalf-year Report
25th Jul 202212:00 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSTrading Update
20th Jun 20222:31 pmRNSResults of AGM
10th Jun 202212:21 pmRNSDirector/PDMR Shareholding
9th Jun 20225:53 pmRNSAnnual Report & Notice of AGM - Correction
7th Jun 20227:00 amRNSAnnual Report & Notice of AGM
30th May 20224:22 pmRNSDirector/PDMR Shareholding
30th May 20227:00 amRNSDirectorate Changes
23rd May 20224:27 pmRNSHolding(s) in Company
20th May 20227:00 amRNSInvestor Presentation
17th May 20227:00 amRNSDirectorate Changes
17th May 20227:00 amRNSFinal Results
10th May 202211:31 amRNSExercise of Share Options & Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.